Abstract Title:

[Effect of 764-3 on ventricular collagen deposition in pulmonary hypertension induced by chronic hypoxia and monocrotaline in rats].

Abstract Source:

Zhongguo Zhong Xi Yi Jie He Za Zhi. 1998 Feb;18(2):97-100. PMID: 11367654

Abstract Author(s):

Z Liu, X Cheng, R Cai

Article Affiliation:

Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037.

Abstract:

OBJECTIVE: To observe the effect of 764-3 on ventricular collagen deposition in pulmonary hypertension induced by chronic hypoxia or monocrotaline (MCT) in rats. METHODS: Wistar rats were divided into 10 groups. The hypobaric hypoxia group received 764-3 20 mg/kg once daily subcutaneously and the MCT group treated with 764-3 40 mg/kg once daily. The hemodynamic and biochemical parameters were measured. RESULTS: At the time of 2 weeks and 4 weeks after treated with hypoxia or MCT, the pulmonary arterial pressure (PAP) of rats raised significantly and the right ventricular collagen content (RVCC) increased markedly. 764-3 could reduce the raised PAP induced either by hypoxia or MCT. It could lower the elevated RVCC of hypobaric hypoxia group at 2 weeks from 76.3 +/- 13.3 to 59.4 +/- 11.4 (P<0.01), and the RVCC of MCT group lowered from 293.4 +/- 73.9 to 210.1 +/- 37.6(P<0.01). CONCLUSION: 764-3 could partially prevent right ventricular collagen deposition induced by hypoxia and has therapeutic effect on that induced by MCT.

Study Type : Animal Study

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.